If you wish to receive Everest Medicines Limited information by email, please choose your options for email notification, enter your email address and information below and click "Submit".
2021-07-13
VOLUNTARY ANNOUNCEMENT STRATEGIC COLLABORATION WITH MEDBANKS HEALTH TECHNOLOGY CO., LTD TO DEVELOP INNOVATIVE HEALTHCARE SERVICE SOLUTIONS FOR PARTIENTS IN CHINA
2021-07-12
VOLUNTARY ANNOUNCEMENT ENTERING INTO STRATEGIC COMMERCIAL PARTNERSHIP WITH TENCENT
2021-07-07
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED JUNE 30, 2021
2021-07-05
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON LICENSING PARTNER SPERO THERAPEUTICS, INC. ENTERED INTO LICENSING AGREEMENT WITH PFIZER INC. FOR SPR206 IN EX-UNITED STATES AND EX-ASIA TERRITORIES
2021-06-22
GRANT OF SHARE AWARDS
2021-06-07
NEXT DAY DISCLOSURE RETURN
2021-06-05
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED MAY 31, 2021
2021-06-01
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON TUESDAY, 1 JUNE 2021
2021-05-20
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON CHINA NMPA GRANTING PRIORITY REVIEW FOR SACITUZUMAB GOVITECAN-HZIY IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER
2021-05-17
VOLUNTARY ANNOUNCEMENT BUSINESS UPDATE ON CHINA NMPA ACCEPTING BIOLOGICS LICENSE APPLICATION FOR SACITUZUMAB GOVITECAN-HZIY IN METASTATIC TRIPLE-NEGATIVE BREAST CANCER
